ATE227296T1 - Phosphoepoxide, verfahren zu deren herstellung und ihre verwendungen - Google Patents
Phosphoepoxide, verfahren zu deren herstellung und ihre verwendungenInfo
- Publication number
- ATE227296T1 ATE227296T1 AT99940246T AT99940246T ATE227296T1 AT E227296 T1 ATE227296 T1 AT E227296T1 AT 99940246 T AT99940246 T AT 99940246T AT 99940246 T AT99940246 T AT 99940246T AT E227296 T1 ATE227296 T1 AT E227296T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- production
- phosphoepoxides
- phosphoepoxide
- lymphocytes
- Prior art date
Links
- 241000288906 Primates Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 150000001767 cationic compounds Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910001411 inorganic cation Inorganic materials 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 150000002892 organic cations Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9810914A FR2782722B1 (fr) | 1998-09-01 | 1998-09-01 | Nouveaux composes phosphoepoxydes, procede de fabrication et applications |
PCT/FR1999/002057 WO2000012519A1 (fr) | 1998-09-01 | 1999-08-27 | Phosphoepoxydes, procede de fabrication et applications |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE227296T1 true ATE227296T1 (de) | 2002-11-15 |
Family
ID=9530020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99940246T ATE227296T1 (de) | 1998-09-01 | 1999-08-27 | Phosphoepoxide, verfahren zu deren herstellung und ihre verwendungen |
Country Status (12)
Country | Link |
---|---|
US (2) | US7101711B1 (de) |
EP (1) | EP1109818B1 (de) |
JP (1) | JP2002523515A (de) |
AT (1) | ATE227296T1 (de) |
AU (1) | AU5426599A (de) |
CA (1) | CA2341578A1 (de) |
DE (1) | DE69903838T2 (de) |
DK (1) | DK1109818T3 (de) |
ES (1) | ES2187184T3 (de) |
FR (1) | FR2782722B1 (de) |
PT (1) | PT1109818E (de) |
WO (1) | WO2000012519A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2782722B1 (fr) * | 1998-09-01 | 2001-01-12 | Inst Nat Sante Rech Med | Nouveaux composes phosphoepoxydes, procede de fabrication et applications |
FR2791981B1 (fr) * | 1999-04-06 | 2001-07-20 | Inst Nat Sante Rech Med | Composes inhibant selectivement les lymphocytes tgamma9delta2, et leurs applications |
FR2833266B1 (fr) * | 2001-12-11 | 2004-10-22 | Mayoly Spindler Lab | Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2 |
FR2836483B1 (fr) * | 2002-02-22 | 2006-09-15 | Innate Pharma | Procedes de production de lymphocytes gamma delta t |
ATE441420T1 (de) * | 2002-12-02 | 2009-09-15 | Innate Pharma | Interleukin-2 und gamma delta t zellaktivator enthaltende zusammensetzungen und deren verwendungen |
WO2005077411A2 (en) * | 2004-02-10 | 2005-08-25 | Innate Pharma | Composition and method for the treatment of carcinoma |
WO2005102385A1 (en) * | 2004-04-26 | 2005-11-03 | Innate Pharma | Adjuvant composition and methods for its use |
WO2006067635A2 (en) * | 2004-12-20 | 2006-06-29 | Innate Pharma S.A. | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT |
US7683045B2 (en) * | 2005-03-22 | 2010-03-23 | Innate Pharma S.A. | Class of γδ T cells activators and use thereof |
WO2007039635A2 (en) * | 2005-10-06 | 2007-04-12 | Innate Pharma | Phosphoantigen salts of organic bases and methods for their crystallization |
EP2083830A1 (de) | 2006-11-17 | 2009-08-05 | Innate Pharma | Verbesserte verfahren zur verwendung von phosphoantigen zur behandlung von krebs |
EP2123285A1 (de) * | 2008-05-21 | 2009-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nucleosid-Phosphorantigene zur Verwendung in der VGAMMA9VDELTA2-T-Zellen-vermittelten Therapie |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639653A (en) * | 1993-07-19 | 1997-06-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva Universtiy | Method for proliferating Vγ2Vδ2 T cells |
FR2715660A1 (fr) * | 1994-01-28 | 1995-08-04 | Centre Nat Rech Scient | Composés organo-phosphorés activateurs des lymphocytes Tgammadelta, procédé pour préparer et/ou isoler et/ou caractériser ces composés, compositions et utilisations pharmaceutiques. |
FR2782722B1 (fr) * | 1998-09-01 | 2001-01-12 | Inst Nat Sante Rech Med | Nouveaux composes phosphoepoxydes, procede de fabrication et applications |
FR2782721B1 (fr) * | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | Nouveaux composes phosphohalohydrines, procede de fabrication et applications |
-
1998
- 1998-09-01 FR FR9810914A patent/FR2782722B1/fr not_active Expired - Fee Related
-
1999
- 1999-08-27 DE DE69903838T patent/DE69903838T2/de not_active Expired - Lifetime
- 1999-08-27 AU AU54265/99A patent/AU5426599A/en not_active Abandoned
- 1999-08-27 WO PCT/FR1999/002057 patent/WO2000012519A1/fr active IP Right Grant
- 1999-08-27 EP EP99940246A patent/EP1109818B1/de not_active Expired - Lifetime
- 1999-08-27 PT PT99940246T patent/PT1109818E/pt unknown
- 1999-08-27 ES ES99940246T patent/ES2187184T3/es not_active Expired - Lifetime
- 1999-08-27 JP JP2000567540A patent/JP2002523515A/ja active Pending
- 1999-08-27 AT AT99940246T patent/ATE227296T1/de not_active IP Right Cessation
- 1999-08-27 CA CA002341578A patent/CA2341578A1/fr not_active Abandoned
- 1999-08-27 DK DK99940246T patent/DK1109818T3/da active
- 1999-08-27 US US09/786,055 patent/US7101711B1/en not_active Expired - Fee Related
-
2006
- 2006-08-29 US US11/512,855 patent/US7432253B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20060287274A1 (en) | 2006-12-21 |
PT1109818E (pt) | 2003-02-28 |
FR2782722A1 (fr) | 2000-03-03 |
ES2187184T3 (es) | 2003-05-16 |
US7432253B2 (en) | 2008-10-07 |
FR2782722B1 (fr) | 2001-01-12 |
DE69903838D1 (de) | 2002-12-12 |
US7101711B1 (en) | 2006-09-05 |
WO2000012519A1 (fr) | 2000-03-09 |
JP2002523515A (ja) | 2002-07-30 |
AU5426599A (en) | 2000-03-21 |
DE69903838T2 (de) | 2003-07-10 |
DK1109818T3 (da) | 2003-03-03 |
EP1109818B1 (de) | 2002-11-06 |
EP1109818A1 (de) | 2001-06-27 |
CA2341578A1 (fr) | 2000-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69901717T2 (de) | Phosphohalohydrine, verfahren zu deren herstellung und verwendungen | |
DE69319976D1 (de) | 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline | |
PT618190E (pt) | 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas | |
ATE215530T1 (de) | 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel | |
CA2160137A1 (en) | Bicyclic Ansamycins | |
DK0830350T3 (da) | Hidtil ukendte N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[B][1,5]diazepin-3-yl)acetamider | |
ATE227296T1 (de) | Phosphoepoxide, verfahren zu deren herstellung und ihre verwendungen | |
MX9604367A (es) | Hidroxipiridinonas novedosas. | |
ES2193241T3 (es) | Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
ES2151168T3 (es) | N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
DE69627344T2 (de) | N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide | |
TR200001819T2 (tr) | COPD tedavi yöntemi. | |
DE69520947T2 (de) | Diarinopropanole abgeleitet von aminosäuren | |
DE69533214D1 (de) | 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme | |
BR9407232A (pt) | Compostos de tiocarbamoíla | |
DE69711506T2 (de) | Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung | |
ES2185154T3 (es) | Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia. | |
TH20016A (th) | กลูโคไพแรโนไซด์ เบนโซไธโอฟีน | |
YU49004B (sh) | LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE | |
TH13553EX (th) | กรรมวิธีที่ดีขึ้นสำหรับเตรียมเซฟาโลสพอรินส์ | |
TH35977A (th) | อนุพันธ์ต่าง ๆ ของไทรอะโซโลพิริมิดีน | |
IT1276893B1 (it) | 1,3,2-benzoossiazafosfolidine sostituite e procedimento per la loro preparazione | |
MX9706968A (es) | Compuesto de tiocarbamoilo. | |
TH35977EX (th) | อนุพันธ์ต่าง ๆ ของไทรอะโซโลพิริมิดีน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1109818 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |